Sfoglia per Autore
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center
2007-01-01 Elisei, Rossella; Romei, Cristina; Cosci, Barbara; Agate, Laura; Bottici, Valeria; Molinaro, Eleonora; Sculli, M; Miccoli, Paolo; Basolo, Fulvio; Grasso, Lucia; Pacini, F; Pinchera, Aldo
Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease.
2008-01-01 Agate, Laura; Mariotti, Stefano; Elisei, Rossella; Mossa, P; Pacini, F; Molinaro, Eleonora; Grasso, Lucia; Masserini, Lucio; Mokhort, T; Vorontsova, T; Arynchyn, A; Tronko, Md; Tsyb, A; Feldt Rasmussen, U; Juul, A; Pinchera, Aldo
RET point mutations in Thyroid Carcinoma
2008-01-01 Elisei, Rossella; Romei, Cristina; Cosci, Barbara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo
Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment
2008-01-01 Miasaki, Fy; Vivaldi, A; Ciampi, Raffaele; Agate, Laura; Collecchi, P; Capodanno, A; Pinchera, Aldo; Elisei, Rossella
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10-year follow-up study
2008-01-01 Elisei, Rossella; Cosci, Barbara; Romei, Cristina; Bottici, Valeria; Renzini, Giulia; Molinaro, Eleonora; Agate, Laura; Vivaldi, Agnese; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Berti, Piero; Pacini, Furio; Pinchera, Aldo
Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy
2009-01-01 Molinaro, Eleonora; Viola, David; Passannanti, P; Agate, Laura; Lippi, F; Ceccarelli, C; Pinchera, Aldo; Elisei, Rossella
Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid
2009-01-01 Vivaldi, A; Miasaki, Fy; Ciampi, Raffaele; Agate, Laura; Collecchi, P; Capodanno, A; Pinchera, Aldo; Elisei, Rossella
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
2010-01-01 Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study.
2011-01-01 Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Romei, C.; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2011-01-01 Romei, Cristina; Cosci, Barbara; Renzini, G.; Bottici, Valeria; Molinaro, Eleonora; Agate, Laura; Passannanti, PAOLO FRANCESCO; Viola, David; Biagini, Agnese; Basolo, Fulvio; Ugolini, C.; Materazzi, Gabriele; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer
2011-01-01 Cosci, B.; Vivaldi, A.; Romei, Cristina; Gemignani, Federica; Landi, Stefano; Ciampi, Raffaele; Tacito, Alessia; Molinaro, E.; Agate, Laura; Bottici, Valeria; Cappagli, V.; Viola, David; Piaggi, P.; Vitti, Paolo; Pinchera, A.; Elisei, Rossella
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study
2012-01-01 Elisei, Rossella; Viola, David; Torregrossa, L; Giannini, Riccardo; Romei, Cristina; Ugolini, C; Molinaro, Eleonora; Agate, Laura; Biagini, Agnese; Lupi, C; Valerio, Laura; Materazzi, Gabriele; Miccoli, Paolo; Piaggi, Paolo; Pinchera, Aldo; Vitti, Paolo; Basolo, Fulvio
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center
2012-01-01 Elisei, Rossella; Romei, Cristina; Renzini, Giulia; Bottici, Valeria; Cosci, Barbara; Molinaro, Eleonora; Agate, Laura; Cappagli, Virginia; Miccoli, Paolo; Berti, Piero; Faviana, Pinuccia; Ugolini, Clara; Basolo, Fulvio; Vitti, Paolo; Pinchera, Aldo
Thyroid incidentaloma
2012-01-01 Elisei, Rossella; Agate, Laura
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study.
2012-01-01 Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line
2012-01-01 Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.
2012-01-01 Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella
New and old knowledge on differentiated thyroid cancer epidemiology and risk factors.
2012-01-01 Agate, Laura; Lorusso, L; Elisei, Rossella
Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients
2013-01-01 Matrone, A; Gambale, C; Taddei, D; Nencetti, C; Molinaro, E; Agate, L; Bottici, V; Viola, D; Vitti, P; Elisei, R
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center.
2013-01-01 D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center | 1-gen-2007 | Elisei, Rossella; Romei, Cristina; Cosci, Barbara; Agate, Laura; Bottici, Valeria; Molinaro, Eleonora; Sculli, M; Miccoli, Paolo; Basolo, Fulvio; Grasso, Lucia; Pacini, F; Pinchera, Aldo | |
| Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease. | 1-gen-2008 | Agate, Laura; Mariotti, Stefano; Elisei, Rossella; Mossa, P; Pacini, F; Molinaro, Eleonora; Grasso, Lucia; Masserini, Lucio; Mokhort, T; Vorontsova, T; Arynchyn, A; Tronko, Md; Tsyb, A; Feldt Rasmussen, U; Juul, A; Pinchera, Aldo | |
| RET point mutations in Thyroid Carcinoma | 1-gen-2008 | Elisei, Rossella; Romei, Cristina; Cosci, Barbara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo | |
| Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment | 1-gen-2008 | Miasaki, Fy; Vivaldi, A; Ciampi, Raffaele; Agate, Laura; Collecchi, P; Capodanno, A; Pinchera, Aldo; Elisei, Rossella | |
| Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10-year follow-up study | 1-gen-2008 | Elisei, Rossella; Cosci, Barbara; Romei, Cristina; Bottici, Valeria; Renzini, Giulia; Molinaro, Eleonora; Agate, Laura; Vivaldi, Agnese; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Berti, Piero; Pacini, Furio; Pinchera, Aldo | |
| Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy | 1-gen-2009 | Molinaro, Eleonora; Viola, David; Passannanti, P; Agate, Laura; Lippi, F; Ceccarelli, C; Pinchera, Aldo; Elisei, Rossella | |
| Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid | 1-gen-2009 | Vivaldi, A; Miasaki, Fy; Ciampi, Raffaele; Agate, Laura; Collecchi, P; Capodanno, A; Pinchera, Aldo; Elisei, Rossella | |
| Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. | 1-gen-2010 | Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo | |
| Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. | 1-gen-2011 | Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Romei, C.; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella | |
| RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) | 1-gen-2011 | Romei, Cristina; Cosci, Barbara; Renzini, G.; Bottici, Valeria; Molinaro, Eleonora; Agate, Laura; Passannanti, PAOLO FRANCESCO; Viola, David; Biagini, Agnese; Basolo, Fulvio; Ugolini, C.; Materazzi, Gabriele; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer | 1-gen-2011 | Cosci, B.; Vivaldi, A.; Romei, Cristina; Gemignani, Federica; Landi, Stefano; Ciampi, Raffaele; Tacito, Alessia; Molinaro, E.; Agate, Laura; Bottici, Valeria; Cappagli, V.; Viola, David; Piaggi, P.; Vitti, Paolo; Pinchera, A.; Elisei, Rossella | |
| The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study | 1-gen-2012 | Elisei, Rossella; Viola, David; Torregrossa, L; Giannini, Riccardo; Romei, Cristina; Ugolini, C; Molinaro, Eleonora; Agate, Laura; Biagini, Agnese; Lupi, C; Valerio, Laura; Materazzi, Gabriele; Miccoli, Paolo; Piaggi, Paolo; Pinchera, Aldo; Vitti, Paolo; Basolo, Fulvio | |
| The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center | 1-gen-2012 | Elisei, Rossella; Romei, Cristina; Renzini, Giulia; Bottici, Valeria; Cosci, Barbara; Molinaro, Eleonora; Agate, Laura; Cappagli, Virginia; Miccoli, Paolo; Berti, Piero; Faviana, Pinuccia; Ugolini, Clara; Basolo, Fulvio; Vitti, Paolo; Pinchera, Aldo | |
| Thyroid incidentaloma | 1-gen-2012 | Elisei, Rossella; Agate, Laura | |
| BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. | 1-gen-2012 | Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line | 1-gen-2012 | Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella | |
| Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. | 1-gen-2012 | Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella | |
| New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. | 1-gen-2012 | Agate, Laura; Lorusso, L; Elisei, Rossella | |
| Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients | 1-gen-2013 | Matrone, A; Gambale, C; Taddei, D; Nencetti, C; Molinaro, E; Agate, L; Bottici, V; Viola, D; Vitti, P; Elisei, R | |
| Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. | 1-gen-2013 | D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile